Using telehealth to improve HIV prevention for sexual minority men in Nigeria
Developing and testing a telehealth intervention to increase HIV pre-exposure prophylaxis uptake and adherence among sexual minority men in Nigeria
This study is looking to improve how sexual minority men in Nigeria can access and stick to taking PrEP, a medication that helps prevent HIV, by using telehealth services and talking to people about their experiences and needs.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-10916473 on NIH RePORTER |
What this research studies
This research aims to develop and test a telehealth intervention designed to increase the uptake and adherence to pre-exposure prophylaxis (PrEP) among sexual minority men in Nigeria, who are at a higher risk for HIV. The approach involves conducting qualitative interviews with HIV-negative sexual minority men, peer educators, and healthcare providers to understand the best ways to implement telemedicine for PrEP services. By addressing barriers to access, this intervention seeks to enhance the delivery of HIV prevention methods through technology. The ultimate goal is to create a sustainable model that can significantly reduce HIV incidence in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-negative sexual minority men living in Nigeria who are at risk of HIV exposure.
Not a fit: Patients who are already HIV-positive or those who do not identify as sexual minority men may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased access to HIV prevention methods, thereby reducing the incidence of HIV among sexual minority men in Nigeria.
How similar studies have performed: Previous telehealth interventions in the U.S. have shown success in increasing PrEP uptake and adherence among sexual minority men, suggesting a promising approach for this population in Nigeria.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Ogunbajo, Adedotun — Rand Corporation
- Study coordinator: Ogunbajo, Adedotun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.